Joe Paduda and Matthew Holt's brainchild is alive and well (and much easier to read than Grand Rounds with a manageable number of posts). Matt's our fearless leader this week, so head over for the best policy/technology/medical business writings of the last two weeks.
I'll be your host next time, so any feedback on the last two series is welcome.
Comments